Patents by Inventor Holli Cherevka

Holli Cherevka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING DISEASES ASSOCIATED WITH RESPIRATORY VIRUSES
    Publication number: 20220211819
    Abstract: The present disclosure provides a method of treating a disease associated with a respiratory virus. The method comprises administering an effective amount of a pharmaceutical composition prepared by removing albumin from a solution of a human serum albumin composition and/or comprising a diketopiperazine with amino acid side chains of aspartic acid and alanine (DA-DKP), such as a low molecular weight fraction of human serum albumin. The present disclosure also provides a pharmaceutical product as well as a kit comprising DA-DKP.
    Type: Application
    Filed: March 21, 2022
    Publication date: July 7, 2022
    Inventors: David Bar-Or, Holli Cherevka
  • Methods for treating diseases associated with respiratory viruses
    Patent number: 11278598
    Abstract: The present disclosure provides a method of treating a disease associated with a respiratory virus. The method comprises administering an effective amount of a pharmaceutical composition prepared by removing albumin from a solution of a human serum albumin composition and/or comprising a diketopiperazine with amino acid side chains of aspartic acid and alanine (DA-DKP), such as a low molecular weight fraction of human serum albumin. The present disclosure also provides a pharmaceutical product as well as a kit comprising DA-DKP.
    Type: Grant
    Filed: September 22, 2021
    Date of Patent: March 22, 2022
    Assignee: Ampio Pharmaceuticals, Inc.
    Inventors: David Bar-Or, Holli Cherevka
  • METHODS FOR TREATING DISEASES ASSOCIATED WITH RESPIRATORY VIRUSES
    Publication number: 20220008517
    Abstract: The present disclosure provides a method of treating a disease associated with a respiratory virus. The method comprises administering an effective amount of a pharmaceutical composition prepared by removing albumin from a solution of a human serum albumin composition and/or comprising a diketopiperazine with amino acid side chains of aspartic acid and alanine (DA-DKP), such as a low molecular weight fraction of human serum albumin. The present disclosure also provides a pharmaceutical product as well as a kit comprising DA-DKP.
    Type: Application
    Filed: September 22, 2021
    Publication date: January 13, 2022
    Inventors: David Bar-Or, Holli Cherevka
  • METHODS FOR TREATING DISEASES ASSOCIATED WITH RESPIRATORY VIRUSES
    Publication number: 20210308230
    Abstract: The present disclosure provides a method of treating a disease associated with a respiratory virus. The method comprises administering an effective amount of a pharmaceutical composition prepared by removing albumin from a solution of a human serum albumin composition and/or comprising a diketopiperazine with amino acid side chains of aspartic acid and alanine (DA-DKP), such as a low molecular weight fraction of human serum albumin. The present disclosure also provides a pharmaceutical product as well as a kit comprising DA-DKP.
    Type: Application
    Filed: March 24, 2021
    Publication date: October 7, 2021
    Inventors: David Bar-Or, Holli Cherevka
  • Methods for treating diseases associated with respiratory viruses
    Patent number: 11129878
    Abstract: The present disclosure provides a method of treating a disease associated with a respiratory virus. The method comprises administering an effective amount of a pharmaceutical composition prepared by removing albumin from a solution of a human serum albumin composition and/or comprising a diketopiperazine with amino acid side chains of aspartic acid and alanine (DA-DKP), such as a low molecular weight fraction of human serum albumin. The present disclosure also provides a pharmaceutical product as well as a kit comprising DA-DKP.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: September 28, 2021
    Assignee: AMPIO PHARMACEUTICALS, INC.
    Inventors: David Bar-Or, Holli Cherevka